Heart Institute research published in Arteriosclerosis, Thrombosis, and Vascular Biology

February 23, 2022

Erin Mulvihill's research program achieves significant milestone

A high-impact study led by Erin Mulvihill, PhD, of the University of Ottawa Heart Institute is published in the February issue of Arteriosclerosis, Thrombosis, and Vascular Biology, a premier journal of the American Heart Association.

Graduate student Nadya Morrow co-led the project. The study investigated whether nobiletin, a dietary flavonoid, targets the intestine to improve metabolic dysregulation in a murine model.

Learn more about Dr. Mulvihill’s independent research program, established in 2017.

Read the study: Nobiletin Prevents High-Fat Diet-Induced Dysregulation of Intestinal Lipid Metabolism and Attenuates Postprandial Lipemia

Media contact

Leigh Morris
Communications Officer
University of Ottawa Heart Institute
613-316-6409 (cell)